Goldman Sachs maintains a "Buy" rating for Colgate-Palmolive (NYSE:CL), raising the price target from $91 to $94.The company reported a 4% increase in earnings per share and a 5.8% rise in net sales for the fourth quarter of 2025.Effective pricing strategies and robust brand leadership in oral care and pet nutrition segments drive growth, particularly in Latin America.Colgate-Palmolive (NYSE:CL) is a global leader in consumer products, specializing in oral care, personal care, home care, and pet nutrition. ...

Core Viewpoint - Colgate-Palmolive Company is experiencing a positive market response with a 6.10% increase in stock price, attributed to an optimistic outlook for 2026 despite previous profit challenges [1]. Group 1: Financial Performance - In 2025, Colgate-Palmolive reported a 26% decrease in attributable net income, falling to $2.13 billion from $2.89 billion in 2024 [4]. - Net sales for 2025 increased by 1.4% to $20.38 billion, up from $20.1 billion, despite a negative impact of 0.7% from lower private label pet volume [4]. - In Q4 2025, the company reported an attributable net loss of $37 million, a significant drop from a net income of $739 million in 2024, while net sales grew by 5.78% to $5.23 billion from $4.94 billion [5]. Group 2: Future Projections - Colgate-Palmolive expects net sales growth of 2 to 6 percent for the full year 2026, factoring in low single-digit foreign exchange gains [2]. - Organic sales are projected to increase by 1 to 4 percent, with a 20-basis point impact from the exit of its pet food brand [3]. - The company anticipates a continued difficult operating environment and slower category growth in the short term, although it is operating from a position of strength [3].

Core Viewpoint - Colgate-Palmolive is experiencing strong financial performance, with a positive outlook from analysts, driven by growth in net sales and earnings per share, particularly in oral care and pet nutrition segments [2][4]. Financial Performance - The company reported earnings per share of $0.95 for Q4 2025, exceeding the Zacks Consensus Estimate of $0.91 [2][6]. - Net sales for Q4 increased by 5.8% to $5.23 billion, surpassing expectations by 2.79%, primarily due to a 2.7% increase in pricing [3][6]. Market Position - Colgate-Palmolive's stock is currently priced at $89.59, reflecting a 5.10% increase, with a market capitalization of approximately $72.22 billion [5]. - The stock has shown volatility, fluctuating between $87.70 and $90.71 during the day, with a 52-week high of $100.18 and a low of $74.55 [5]. Growth Drivers - The growth in organic sales in Latin America was significant, with a 6.5% increase supported by higher pricing, increased volumes, and favorable currency effects [3]. - Robust demand in oral care and pet nutrition has contributed to the company's impressive financial results [4]. Analyst Outlook - Piper Sandler has raised Colgate-Palmolive's price target to $96, indicating a potential 7.32% increase from its current trading price [2][6].

In response to questions about 2026 guidance, Wallace said category growth appears to have stabilized, but at lower levels than historical assumptions. He cited a range of roughly 1.5% to 2.5% category growth, alongside “significant uncertainty all around the world,” including the risk of higher promotional intensity if demand stays weak.Wallace said Colgate exited the year with organic sales growth in all four categories in the fourth quarter, and showed sequential improvement versus the third quarter in e ...

Core Insights - Colgate-Palmolive reported fourth-quarter earnings and revenue that exceeded expectations, with shares rising over 4% intraday [1] - The company faced a significant impairment charge of $794 million related to its skin health business, impacting GAAP earnings [2] - For full-year 2025, Colgate's net sales increased to $20.38 billion, with adjusted earnings per share rising to $3.69 [3] Financial Performance - Adjusted earnings per share for the fourth quarter were $0.95, surpassing analyst estimates of $0.91 [1] - Revenue for the quarter reached $5.23 billion, exceeding consensus forecasts of $5.12 billion, marking a year-over-year increase of 5.8% [1] - Organic sales growth for the quarter was 2.2%, excluding currency impacts and acquisitions [1] Regional Performance - Latin America showed strong performance with reported sales rising 12.8% and organic growth of 6.5% [2] - The Africa/Eurasia region also experienced robust gains, with reported sales up 15% and organic growth of 10.3% [2] Future Projections - For 2026, Colgate projected net sales growth of 2% to 6%, including a low-single-digit benefit from foreign exchange [3] - Organic sales are expected to rise by 1% to 4% [3] - The company anticipates gross margin expansion, increased advertising investment, and low- to mid-single-digit EPS growth on a non-GAAP basis [3]

Key Takeaways CL topped Q4 estimates as EPS rose 4% to 95 cents and net sales climbed 5.8% to $5.23B.Colgate relied on 2.7% pricing gains to lift organic sales, offsetting volume declines in multiple regions.CL saw Latin America deliver 6.5% organic sales growth, aided by higher pricing, volumes and currency.Colgate-Palmolive Company (CL) has reported fourth-quarter 2025 results, wherein both top and bottom lines increased year over year and surpassed the Zacks Consensus Estimate. Results benefited from sol ...

Second, we are accelerating our investment in new innovation models with additional resources focused on delivering more impactful science-based innovation across all price tiers with greater investment in key strategic growth markets. Next, we're harnessing the power of best-in-class omnichannel demand generation by adapting how the right products with content and messages are delivered to the right people at the moments that matter in order to drive purchase behavior. The goal is to deliver consistency of ...

For the quarter ended December 2025, Colgate-Palmolive (CL) reported revenue of $5.23 billion, up 5.8% over the same period last year. EPS came in at $0.95, compared to $0.91 in the year-ago quarter.The reported revenue represents a surprise of +2.79% over the Zacks Consensus Estimate of $5.09 billion. With the consensus EPS estimate being $0.91, the EPS surprise was +4.02%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...

高露洁(CL.US)盘初涨超6%报90.71美元。消息面上，高露洁报告称，截至12月31日的季度净销售额为 52.3亿美元，高于一年前的49.4亿美元。 本文源自：金融界AI电报 ...

Colgate Stock Jumps After Earnings. Why the Shares Can Keep Investors Smiling. - Barron'sSkip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.# Colgate Stock Jumps After Earnings. Why the Shares Can Keep Investors Smiling.By [Alex Kozul-Wright]ShareResize-- ...